Evolving therapies in the treatment of hepatocellular carcinoma
Hans Christian Spangenberg, Robert Thimme, Hubert E BlumDepartment of Medicine II, University of Freiburg, D-79106 Freiburg, GermanyAbstract: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiologies and risk factors for HCC development are well define...
Guardado en:
Autores principales: | Hans Christian Spangenberg, Robert Thimme, Hubert E Blum |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f20bb1efe6c84d029414f049c8bd3235 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systemic treatment for hepatocellular carcinoma
por: Manushi Aggarwal, et al.
Publicado: (2018) -
Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Junji Furuse
Publicado: (2008) -
Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma
por: Zhou J, et al.
Publicado: (2020) -
Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro
por: Jędrzak A, et al.
Publicado: (2020) -
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou X, et al.
Publicado: (2012)